Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Kulkarni

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Plos One|March 10, 2011
Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studySong Yao, Lara E Sucheston, Amy E Millen, et al.
Scientific Reports|July 15, 2022
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticlesDorota Lubanska, Sami Alrashed, Gage T Mason, et al.
Iscience|June 13, 2024
ESR1 and p53 interactome alteration defines mechanisms of tamoxifen response in luminal breast cancerChetan C Oturkar, Spencer R Rosario, Alan D Hutson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2009
Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional studyCatherine Ibarra-Drendall, Lee G Wilke, Carola Zalles, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2021
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLCNatasha B Leighl, Scott A Laurie, Glenwood D Goss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 StudyPatrick Neven, Nicole Stahl, Maria Vidal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023Therese B Bevers, Bethany L Niell, Jennifer L Baker, et al.
Cancer Research|August 17, 2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancerKristen N Stevens, Celine M Vachon, Adam M Lee, et al.
Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Plos One|March 10, 2011
Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series studySong Yao, Lara E Sucheston, Amy E Millen, et al.
Scientific Reports|July 15, 2022
Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticlesDorota Lubanska, Sami Alrashed, Gage T Mason, et al.
Iscience|June 13, 2024
ESR1 and p53 interactome alteration defines mechanisms of tamoxifen response in luminal breast cancerChetan C Oturkar, Spencer R Rosario, Alan D Hutson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2009
Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional studyCatherine Ibarra-Drendall, Lee G Wilke, Carola Zalles, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 20, 2021
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLCNatasha B Leighl, Scott A Laurie, Glenwood D Goss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2024
A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 StudyPatrick Neven, Nicole Stahl, Maria Vidal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2023
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023Therese B Bevers, Bethany L Niell, Jennifer L Baker, et al.
Cancer Research|August 17, 2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancerKristen N Stevens, Celine M Vachon, Adam M Lee, et al.
Nature Genetics|November 1, 2011
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancerChristopher A Haiman, Gary K Chen, Celine M Vachon, et al.
Pageof 8